1MAR
REFINED 1.8 ANGSTROMS STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZOPOLRESTAT
Experimental procedure
Spacegroup name | P 1 |
Unit cell lengths | 47.640, 48.040, 40.480 |
Unit cell angles | 64.47, 76.77, 76.07 |
Refinement procedure
Resolution | 12.000 - 1.800 |
R-factor | 0.18 |
Rwork | 0.180 |
RMSD bond length | 0.006 |
RMSD bond angle | 1.650 |
Phasing software | X-PLOR |
Refinement software | X-PLOR |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 20.000 * |
High resolution limit [Å] | 1.800 * |
Rmerge | 0.034 * |
Total number of observations | 53037 * |
Number of reflections | 26145 * |
Completeness [%] | 90.4 * |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | Vapor diffusion, hanging drop * | 5 * |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | drop | ALR2 | 7 (mg/ml) | |
2 | 1 | drop | zopolrestat | 0.2 (mM) | |
3 | 1 | drop | 2-mercaptoethanol | 3.5 (mM) | |
4 | 1 | drop | citrate | 25 (mM) | |
5 | 1 | reservoir | PEG6000 | 17 (%) | |
6 | 1 | reservoir | 2-mercaptoethanol | 7 (mM) | |
7 | 1 | reservoir | citrate | 50 (mM) |